ERBB2 and breast carcinoma: This has been demonstrated by preventing tumor formation in a genetically modified mouse model with higher basal autophagy levels and by decreasing tumor growth in HER2+ breast cancer xenografts treated with Tat-BECN1, an autophagy-inducing peptide [34].